Corcept Therapeutics Director Daniel N. Swisher Jr. Sells $111K of Stock
Daniel N. Swisher Jr., Director, sold 1,500 shares of Corcept Therapeutics Inc at $74.07 a share, worth $111K in total on Nov 10, 2026. Shares held after the trade: 0 (-100.0%).
Corcept Therapeutics Insider Sean Maduck Sells $2.05M of Stock
Sean Maduck sold 25,000 shares of Corcept Therapeutics Inc at $81.42 to $82.68 a share (average $81.85) in 3 transactions, worth $2.05M in total between Nov 2, 2026 and Nov 3, 2026. Shares held after the trade: 9,938 (-31.4%).
Roberto Wandenkolk Vieira, President, Oncology, sold 8,333 shares of Corcept Therapeutics Inc at $80.73 to $81.52 a share (average $80.89) in 2 transactions, worth $674K in total on Nov 2, 2026. Shares held after the trade: 3,946 (-29.8%).
Corcept Therapeutics Director James N. Wilson Sells $1.15M of Stock
James N. Wilson, Director, sold 10,000 shares of Corcept Therapeutics Inc at $114.48 to $116.30 a share (average $114.81) in 3 transactions, worth $1.15M in total on Oct 15, 2026. Shares held after the trade: 1,054,543 (-0.0%).
Roberto Wandenkolk Vieira, President, Oncology, sold 8,333 shares of Corcept Therapeutics Inc at $114.52 to $116.58 a share (average $116.10) in 3 transactions, worth $967K in total on Oct 2, 2026. Shares held after the trade: 3,946 (-56.6%).
Corcept Therapeutics Insider Joseph Douglas Lyon Sells $1.16M of Stock
Joseph Douglas Lyon sold 10,000 shares of Corcept Therapeutics Inc at $115.40 to $116.54 a share (average $116.07) in 3 transactions, worth $1.16M in total between Oct 1, 2026 and Oct 2, 2026. Shares held after the trade: 5,683 (-45.5%).
Corcept Therapeutics Insider Sean Maduck Sells $2.91M of Stock
Sean Maduck sold 25,000 shares of Corcept Therapeutics Inc at $115.54 to $116.55 a share (average $116.26) in 3 transactions, worth $2.91M in total between Oct 1, 2026 and Oct 2, 2026. Shares held after the trade: 9,938 (-46.8%).
Roberto Wandenkolk Vieira, President, Oncology, sold 296 shares of Corcept Therapeutics Inc at $100.82 a share, worth $29.8K in total on Sep 16, 2026. Shares held after the trade: 3,946 (-7.0%).
Corcept Therapeutics Insider Joseph Douglas Lyon Sells $1.13M of Stock
Joseph Douglas Lyon sold 10,000 shares of Corcept Therapeutics Inc at $113.32 to $114.12 a share (average $113.49) in 2 transactions, worth $1.13M in total on Sep 14, 2026. Shares held after the trade: 5,683 (-27.8%).
Corcept Therapeutics Director James N. Wilson Sells $1.11M of Stock
James N. Wilson, Director, sold 10,000 shares of Corcept Therapeutics Inc at $110.27 to $111.70 a share (average $110.69) in 3 transactions, worth $1.11M in total on Sep 15, 2026. Shares held after the trade: 1,064,543 (-0.3%).